Bertrand C, Nadel J A, Graf P D, Geppetti P
Cardiovascular Research Institute, University of California at San Francisco 94143-0130.
Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):909-14. doi: 10.1164/ajrccm/148.4_Pt_1.909.
The role of NK1 tachykinin receptors in the increase in total pulmonary resistance (RL) produced by release of endogenous tachykinins was investigated in anesthetized guinea pigs pretreated intravenously with atropine (1 mumol/kg) by using the novel nonpeptide antagonists of NK1 (CP-96,345) and NK2 (SR 48968) tachykinin receptors. SR 48968 (0.3 mumol/kg) and CP-96,345 (2 mumol/kg) given intravenously completely blocked the response to the selective NK2 receptor agonist [beta Ala8]neurokinin A(4-10) and NK1 receptor agonist [Sar9,Met(O2)11]substance P, respectively. The response to neurokinin A was reduced dose-dependently, but not abolished, by SR 48968, and it was completely prevented by a combination of SR 48968 and CP-96,345. The response to capsaicin was reduced, but not blocked, by SR 48968, and it was completely abolished by the combination of the two antagonists. The combination of SR 48968 and CP-96,345 did not affect the increase in RL evoked by histamine. Thus, NK1, as well as NK2, receptor activation contributes to the noncholinergic increase in RL evoked by capsaicin and ascribed to release of endogenous tachykinins from sensory nerves.
通过使用新型的NK1(CP-96,345)和NK2(SR 48968)速激肽受体非肽拮抗剂,研究了NK1速激肽受体在麻醉的经静脉注射阿托品(1 μmol/kg)预处理的豚鼠中,内源性速激肽释放所产生的总肺阻力(RL)增加中的作用。静脉注射SR 48968(0.3 μmol/kg)和CP-96,345(2 μmol/kg)分别完全阻断了对选择性NK2受体激动剂[βAla8]神经激肽A(4-10)和NK1受体激动剂[Sar9,Met(O2)11]P物质的反应。SR 48968使对神经激肽A的反应呈剂量依赖性降低,但未消除,而SR 48968和CP-96,345联合使用则完全阻断了该反应。SR 48968使对辣椒素的反应降低但未阻断,两种拮抗剂联合使用则完全消除了该反应。SR 48968和CP-96,345联合使用不影响组胺引起的RL增加。因此,NK1以及NK2受体激活促成了辣椒素引起的、归因于感觉神经释放内源性速激肽的RL非胆碱能增加。